09/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/25/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MosaiQ COVID-19 Antibody Magazine. The MosaiQ COVID-19 Antibody Magazine is authorized for the detection of total (IgM and IgG) antibodies to SARS-CoV-2 in human serum and dipotassium (K2) and tripotassium (K3)EDTA plasma. (PDF)
.png)
No hay comentarios:
Publicar un comentario